相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interferon-γ: teammate or opponent in the tumour microenvironment?
Angela M. Gocher et al.
NATURE REVIEWS IMMUNOLOGY (2022)
RePhine: An Integrative Method for Identification of Drug Response-related Transcriptional Regulators
Xujun Wang et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2021)
CRISPR Screens Identify Essential Cell Growth Mediators in BRAF Inhibitor-resistant Melanoma
Ziyi Li et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2020)
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
Catherine S. Grasso et al.
CANCER CELL (2020)
Functional genomic landscape of cancer-intrinsic evasion of killing by T cells
Keith A. Lawson et al.
NATURE (2020)
Long-distance modulation of bystander tumor cells by CD8+ T-cell-secreted IFN-γ
Mirjam E. Hoekstra et al.
NATURE CANCER (2020)
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
Tuba N. Gide et al.
CANCER CELL (2019)
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
Pengfei Zhao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
LNK suppresses interferon signaling in melanoma
Ling-Wen Ding et al.
NATURE COMMUNICATIONS (2019)
Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis
Melanie Fritsch et al.
NATURE (2019)
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
Jeffrey J. Ishizuka et al.
NATURE (2019)
Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss
Huayang Liu et al.
NATURE MEDICINE (2019)
Interferon-γ signaling is associated with BRCA1 loss-of-function mutations in high grade serous ovarian cancer
Horacio Cardenas et al.
NPJ PRECISION ONCOLOGY (2019)
A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing
Deng Pan et al.
SCIENCE (2018)
STAG2 deficiency induces interferon responses via cGAS-STING pathway and restricts virus infection
Siyuan Ding et al.
NATURE COMMUNICATIONS (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
Christopher S. Garris et al.
IMMUNITY (2018)
Interferon regulatory factor 1 priming of tumour-derived exosomes enhances the antitumour immune response
Mu-qing Yang et al.
BRITISH JOURNAL OF CANCER (2018)
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T. Manguso et al.
NATURE (2017)
Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions
Antje Sucker et al.
NATURE COMMUNICATIONS (2017)
Targeting Ongoing Dna Damage in Multiple Myeloma: effects of Dna Damage response inhibitors on Plasma cell survival
Ana Belen Herrero et al.
FRONTIERS IN ONCOLOGY (2017)
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz et al.
CELL (2017)
SynergyFinder: a web application for analyzing drug combination dose-response matrix data
Aleksandr Ianevski et al.
BIOINFORMATICS (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
Jianjun Gao et al.
CELL (2016)
TC-PTP and PTP1B: Regulating JAK-STAT signaling, controlling lymphoid malignancies
Kelly A. Pike et al.
CYTOKINE (2016)
Identification and characterization of essential genes in the human genome
Tim Wang et al.
SCIENCE (2015)
Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR
Wei Li et al.
GENOME BIOLOGY (2015)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
T-Cell and NK-Cell Infiltration into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy
Ignacio Melero et al.
CANCER DISCOVERY (2014)
IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes
D. Murtas et al.
BRITISH JOURNAL OF CANCER (2013)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
The ICOS/ICOSL Pathway Is Required for Optimal Antitumor Responses Mediated by Anti-CTLA-4 Therapy
Tihui Fu et al.
CANCER RESEARCH (2011)
Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells
Gregory B. Lesinski et al.
BMC CANCER (2010)
Regulation of DNA double-strand break repair pathway choice
Meena Shrivastav et al.
CELL RESEARCH (2008)
L3RCA1 regulates IFN-gamma signaling through a mechanism involving the type IIFNs
Niamh E. Buckley et al.
MOLECULAR CANCER RESEARCH (2007)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
IL-18 bridges innate and adaptive immunity through IFN-γ and the CD134 pathway
Joseph R. Maxwell et al.
JOURNAL OF IMMUNOLOGY (2006)
CCR7 mediates inflammation-associated tumor progression
Yvonne K. Mburu et al.
IMMUNOLOGIC RESEARCH (2006)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Perturbed IFN-γ-jak-signal transducers and activators of transcription signaling in tuberous sclerosis mouse models:: Synergistic effects of rapamycin-IFN-γ treatment
N El-Hashemite et al.
CANCER RESEARCH (2004)
DNA single-strand break repair and spinocerebellar ataxia
KW Caldecott
CELL (2003)
IFNγ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway
S Fulda et al.
ONCOGENE (2002)
The roles of IFNγ in protection against tumor development and cancer immunoediting
H Ikeda et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
IFN-γ-dependent inhibition of tumor angiogenesis by tumor-infiltrating CD4+ T cells requires tumor responsiveness to IFN-γ
GL Beatty et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
